(Q70157895)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Significance of serum bilirubin level in response of hepatocellular carcinoma to doxorubicin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

main subject

hepatocellular carcinoma

1 reference

1 reference

P J Johnson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

A Alexopoulos

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

R D Johnson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

R Williams

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

149-153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025287%20AND%20SRC:MED&resulttype=core&format=json

Induction of remission in hepatocellular carcinoma with doxorubicin

9 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980020-4

7 January 2021

A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980020-4

7 January 2021

Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980020-4

7 January 2021

Chemotherapy for advanced hepatocellular carcinoma Adriamycin versus quadruple chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980020-4

7 January 2021

Primary liver cancer. An Eastern Cooperative Oncology Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980020-4

7 January 2021

Serum bilirubin: a prognostic factor in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980020-4

7 January 2021

Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma.A clinical and pharmacology report

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980020-4

7 January 2021

Treatment of hepatocellular carcinoma with adriamycin.Preliminary communication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980020-4

7 January 2021

Mitozantrone as single agent therapy in hepatocellular carcinoma. A phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980020-4

7 January 2021

10.1016/S0168-8278(86)80020-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference